Envista Holdings Corp (NVST) Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
Sector: Dental Equipment & Supplies
Industry: Medical - Instruments & Supplies
Envista Holdings Corp NYSE:NVST Healthcare · Medical - Equipment & Services
AH Close $23.60 +0.00% vs close
AH Close $23.60 +0.00% vs close
All Press Release SEC Filings News
Press Release
Every Tooth Deserves a Second Chance. Kerr Dental Introduces ZenFlex(TM) RT Rotary Retreatment File System
Kerr Dental, an operating company of Envista Holdings (NVST), launched the ZenFlex RT Rotary Retreatment File System, a dedicated four-file rotary system for endodontic retreatment procedures.
The product features a non-cutting tip, 1.0 mm maximum flute diameter, and proprietary heat treatment for flexibility, designed to preserve tooth structure during retreatment.
The launch is now available through Kerr Dental and authorized dealers; it is a routine line extension with no disclosed financial impact for Envista.
• 10d ago AI analysis › News
Envista Holdings Corporation (NYSE:NVST) Stock Rated “Hold” by Wall Street Brokerages
defenseworld.net • 14d ago News
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
zacks.com • 16d ago News
Here's Why Envista (NVST) is a Strong Growth Stock
zacks.com • 17d ago Press Release
Envista Schedules Third Quarter 2026 Earnings Call
Envista Holdings (NYSE: NVST) will report Q3 2026 financial results on Wednesday, November 4, 2026, with a conference call the same day at 2:00 PM PT.
The call and slide presentation will be webcast on the company's investor-relations site, with a replay available for one year.
This is a scheduling notice only; it contains no financial results or guidance.
• 19d ago AI analysis › News
New Strong Buy Stocks for September 28th
zacks.com • 27d ago News
NVST vs. ABT: Which Stock Is the Better Value Option?
zacks.com • 0mo ago News
Should Value Investors Buy Envista (NVST) Stock?
zacks.com • 1mo ago News
Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)
zacks.com • 1mo ago News
Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript
seekingalpha.com • 1mo ago News
Here's Why Envista (NVST) is a Strong Value Stock
zacks.com • 1mo ago SEC Filing
NVST: 8-K · other
Envista Holdings Corporation will host its 2026 Investor Day on September 17, 2026, during which members of the executive leadership team will present the company's strategy, growth initiatives, innovation priorities, and long-term financial objectives.
The disclosure is furnished under Item 7.01 (Regulation FD), meaning it is informational and not deemed filed under Section 18; the investor day presentation is available on Envista's investor relations website at www.envistaco.com.
The 8-K itself contains no quantitative figures or guidance, so any market impact will depend on the long-term financial targets and innovation roadmap detailed in the presentation itself.
SEC 8-K • 1mo ago News
Envista Holdings Corporation (NVST) Presents at 2026 Global Healthcare Conference Transcript
seekingalpha.com • 1mo ago News
NVST or ABT: Which Is the Better Value Stock Right Now?
zacks.com • 1mo ago Press Release
Envista Announces Participation in Baird 2026 Global Healthcare Conference
Envista will participate in the Baird 2026 Global Healthcare Conference on September 15, 2026.
The company will host a fireside chat from 9:40 to 10:10 AM ET, with a live webcast available on its investor website.
This is a standard investor relations event with no new financial data or guidance disclosed.
• 1mo ago AI analysis › News
Envista (NVST) Up 0.8% Since Last Earnings Report: Can It Continue?
zacks.com • 1mo ago News
New Strong Buy Stocks for August 27th
zacks.com • 1mo ago News
Why Envista (NVST) is a Top Value Stock for the Long-Term
zacks.com • 2mo ago News
Envista (NVST) Upgraded to Strong Buy: Here's What You Should Know
zacks.com • 2mo ago News
NVST or ABT: Which Is the Better Value Stock Right Now?
zacks.com • 2mo ago News
Do Options Traders Know Something About Envista Stock We Don't?
zacks.com • 2mo ago News
Are Investors Undervaluing Envista (NVST) Right Now?
zacks.com • 2mo ago News
4 Stocks Trading Near 52-Week High With More Upside Potential
zacks.com • 2mo ago SEC Filing ⚠ 2
NVST: 8-K · leadership change
Envista Holdings Corporation (NYSE: NVST) appointed President and CEO Paul Keel as Chair of the Board effective August 19, 2026, succeeding Scott Huennekens, who remains a director and becomes Lead Independent Director. Keel has led the company as President, CEO and director since May 2024.
The Compensation Committee approved a $200,000 base salary increase for Keel, from $1.1 million to $1.3 million per year effective August 24, 2026, along with a special one-time equity award valued at $10 million on the date of grant. The award is split between $5 million of RSUs vesting over four years and $5 million of PSUs at target.
CFO Eric Hammes also received a special one-time PSU award valued at $1.5 million, tied to the same performance condition as the CEO's PSUs: the company's four-year total stockholder return percentile rank versus the S&P 400 Health Care Sector Index.
The board framed the awards as retention and alignment incentives for executing its multi-year strategy, though combining the CEO and Chair roles under one person may draw mixed reactions from governance-focused investors.
SEC 8-K • 2mo ago AI analysis › News
Here's Why Envista (NVST) is a Strong Momentum Stock
zacks.com • 2mo ago News
Can NVST Sustain Its 2026 Guidance Boost as Margins Keep Expanding?
zacks.com • 2mo ago News
Is NVST a Buy as Earnings Rebound but Valuation Remains Above Median?
zacks.com • 2mo ago Press Release ⚠ 3
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It
Axogen reported Q2 2026 revenue of $69.7 million, up 23.1% year-over-year, surpassing the consensus of $68.4 million driven by over 50% growth in the breast reconstruction segment.
Despite raising full-year guidance to at least $279 million, the company's adjusted earnings of $0.12 per share missed consensus and gross margins dipped to 72.7%.
The commentary notes Axogen as a commercial-stage proof point for regenerative medicine in reconstructive surgery, though the article itself is a paid promotion for another entity.
• 2mo ago AI analysis › News
Investing in Envista (NVST)? Don't Miss Assessing Its International Revenue Trends
zacks.com • 2mo ago News
Envista Q2 Earnings Call Highlights
marketbeat.com • 2mo ago News
NVST vs. ABT: Which Stock Is the Better Value Option?
zacks.com • 2mo ago News
Here's Why Envista (NVST) is a Strong Value Stock
zacks.com • 2mo ago News
Envista Holdings Corporation (NVST) Q2 2026 Earnings Call Transcript
seekingalpha.com • 2mo ago News
Envista (NVST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com • 2mo ago News
Envista (NVST) Q2 Earnings and Revenues Surpass Estimates
zacks.com • 2mo ago SEC Filing ● Major ⚠ 6
NVST: 10-Q · periodic report
Envista Holdings delivered a standout Q2 2026, with sales of $730.5 million up 7.1% year-over-year and net income more than doubling to $53.7 million ($0.33 diluted EPS vs $0.16 a year ago). Six-month sales rose 10.5% to $1,436.0 million with net income of $92.4 million, up 108.1%.
The profit surge was driven by a 73.4% jump in operating profit to $80.3 million, helped by $12.6 million of IEEPA tariff refunds recorded in cost of sales following the Supreme Court's invalidation of the tariffs, a lower 27.8% effective tax rate (down from 35.1%), and core sales growth of 5.0% led by Western Europe and North America.
On capital allocation, the company bought back $58.6 million of stock in the quarter under programs that now include a new $300 million authorization through 2029 (about $282.9 million remaining), and it closed the $54.7 million acquisition of Versah LLC in February. Envista holds $1,125.6 million in cash against $1,436.3 million of total debt and was in compliance with all debt covenants.
SEC 10-Q • 2mo ago AI analysis › Press Release ● Major
Envista Reports Second Quarter 2026 Results
Envista delivered Q2 sales of $731 million with 5.0% core growth and adjusted diluted EPS of $0.41, representing a 58% increase year-over-year.
Adjusted EBITDA rose 28% to $108 million, driven by 230 basis points of margin expansion, while free cash flow totaled $105 million for the quarter.
Based on the strong performance, the company raised full-year 2026 guidance for core sales growth to 3.5%-4.5% and adjusted EPS to $1.50-$1.55.
The company repurchased 2.4 million shares for approximately $59 million during the quarter, leaving roughly $283 million of authorization remaining.
• 2mo ago AI analysis › News
Envista (NVST) Stock Jumps 5.2%: Will It Continue to Soar?
zacks.com • 2mo ago Press Release
Envista to Host Investor Day on September 17, 2026
Envista Holdings announced it will host an Investor Day on Thursday, September 17, 2026, from 9:00 a.m. to noon EDT.
The event will feature a management presentation followed by a question-and-answer session, available via live webcast and replay on the company's investor relations website.
In-person attendance requires advanced registration, with inquiries directed to the Investor Relations department.
• 2mo ago AI analysis › Press Release
Envista Schedules Second Quarter 2026 Earnings Call
Envista Holdings Corporation announced it will report its second quarter 2026 financial results on Wednesday, August 5, 2026.
The company will host a conference call to discuss the results at 2:00 PM PT on the same day, which will be webcast via the Investors section of its website.
A replay of the webcast will be available for one year, and participants can join by phone using Conference ID #73468.
• 3mo ago AI analysis › SEC Filing
NVST: 8-K · leadership change
Envista Holdings Corp announced that Faez Kaabi will resign as Chief Accounting Officer effective August 6, 2026, citing retirement. The company confirmed the departure is not related to any disagreements over financial disclosures or accounting practices.
Coree Thomas, currently the Vice President and Global Controller, has been appointed as the new Chief Accounting Officer. He will assume the role and serve as principal accounting officer starting August 6, 2026, ensuring a smooth internal transition.
SEC 8-K • 4mo ago AI analysis › SEC Filing
NVST: 8-K · proxy statement
Envista Holdings Corporation reported the voting results from its 2026 Annual Meeting of Stockholders held on May 19, 2026. All eight director nominees were elected with significant majority support, and the appointment of Ernst & Young LLP as independent auditor was ratified.
Stockholders also approved the advisory vote on executive compensation and voted to hold future advisory votes on an annual basis. The filing reflects routine corporate governance activities with no contested proposals or significant dissent.
SEC 8-K • 5mo ago Press Release ● Major
Envista Reports First Quarter 2026 Results
Envista reported first quarter sales of $706 million, reflecting 9.5% core revenue growth driven by customer engagement and new product commercialization.
Profitability expanded significantly with adjusted diluted EPS rising 50% year-over-year to $0.36 and adjusted EBITDA increasing 25% to $99 million.
The company reaffirmed its full-year 2026 guidance and authorized a new $300 million share repurchase program, extending its capital return strategy through 2029.
• 5mo ago AI analysis › Press Release
CooperCompanies Appoints Paul Keel to its Board of Directors
CooperCompanies appointed Paul Keel, former CEO of Envista and Smiths Group, as an independent director effective July 1, 2026.
Keel will also serve on the Audit Committee, bringing extensive experience in the medical device and industrial technology sectors to the board.
The addition aims to strengthen the Board's expertise as Cooper continues to execute its strategy through its CooperVision and CooperSurgical units.
• 5mo ago AI analysis › 2 fund position changes (13F filings)